ArticleBMC pediatrics2025
Epidemiological and genetic characterizations of hand, foot, and mouth disease and acute respiratory infections due to CV-A6 infection in Henan Province, China between 2021 and 2022.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hand, Foot, and Mouth Disease Surveillance in Anhui, After Introduction of the Enterovirus 71 Vaccine and During the COVID-19 Pandemic: Ecological Interrupted Time Series Study.JMIR public health and surveillance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Coxsackievirus (CV) A6 has been widely considered as the main cause of global hand, foot, and mouth disease (HFMD) outbreaks. Despite the serious threat to children's health posed by the emerging CV-A6, our knowledge of the epidemiological features and etiology of HFMD caused by the new CV-A6 strains remains limited. In the present study, we aimed to investigate the epidemiological and genetic characterizations of CV-A6-associated HFMD outbreaks in Henan Province, China between 2021 and 2022. Clinical data and biospecimens of 407 children with mild and severe CV-A6 infection from Henan Children's Hospital (Children's Hospital Affiliated to Zhengzhou University) were collected for this prevalence study. Logistic regression analysis was employed to assess potential risk factors for severe illness. We also sequenced the VP1 gene of 4 CV-A6 strains, and a phylogenetic tree was conducted to characterize the evolutionary features of these CV-A6 strains. The majority of patients were 1 ~ 2 years old (236/407, 62.93%). Rash (364/407, 89.43%) and increase of lung markings in both lungs (224/407, 55.04%) were found to account for the highest percentage of clinical manifestations and clinical examination. Logistic regression analysis showed that boys were more likely to develop critical illness (OR: 1.970; 95% CI: 1.220 ~ 3.180), and that persistent high fever (OR: 2.066; 95% CI: 1.375 ~ 3.105), and elevated procalcitonin (PCT) levels (OR: 2.931; 95% CI: 1.590 ~ 5.405) would increase the risk of developing a critical illness (P < 0.01). The phylogenetic tree indicated that the genotype of CV-A6 strains in Henan Province was the D3 subtype. Collectively, in addition to the rash, acute respiratory infections due to CV-A6 infection are becoming increasingly common. Male sex, persistent high fever, and elevated PCT levels are associated with an increased risk of critical illness in patients infected with the D3 subtype of CV-A6. These findings may provide a scientific basis for guiding the prevention of HFMD and increase clinicians' awareness of CV-A6 infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.